Trials / Completed
CompletedNCT04392531
Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19
Open, Controlled, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Cyclosporine Plus Standard Treatment vs Standard Treatment Only in Hospitalized Patients With COVID-19 Infection
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study hypothesis is that cyclosporine, added to standard treatment of hospitalized patients with COVID19 infection may improve their prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporine | In the experimental group, cyclosporine will be started according to patient weight, and then increased depending on patient tolerance (monitoring renal function and blood pressure) |
| DRUG | Standard treatment | Standard of care according to hospital protocol |
Timeline
- Start date
- 2020-04-16
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
- First posted
- 2020-05-19
- Last updated
- 2022-07-14
Locations
7 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT04392531. Inclusion in this directory is not an endorsement.